Abstract:The efficacy of sonodynamic therapy (SDT) is largely dependent upon oxygen availability to generate deleterious reactive oxygen species, and as such, hypoxic microenvironments greatly constrain the efficacy of SDT. Development of free radical generators that are not dependent on oxygen and related combination treatment strategies thus have the potential to enhance the antitumor potential of SDT. Combined treatment strategies are expected to improve the efficacy of sonodynamic antitumor therapy. As metal–organic framework (MOF) platforms are highly amenable to integration with other therapeutic approaches, we herein report the development of tumor microenvironment (TME)-responsive nanoparticles constructed by embedding the azo initiator 2,2′-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (AIPH) into hypoxia-triggered copper metal–organic framework (Cu-MOF) nanovectors to achieve synergistic sono-chemodynamic therapy in an orthotopic murine pancreatic carcinoma model system. When exposed to hypoxic conditions within the TME, this Cu-MOF structure underwent degradation, leading to the release of Cu2+ and AIPH. Cu2+ was then able to deplete local glutathione stores, resulting in the reduction of Cu2+ to Cu+, which then reacts with endogenous H2O2 in a Fenton-like reaction to yield cytotoxic hydroxyl radicals (•OH) for chemodynamic therapy. When exposed to ultrasound irradiation, AIPH further degraded in an oxygen-independent manner to yield nitrogen bubbles and alkyl radicals, the former of which enhanced the ability of these nanoparticles to penetrate deeply into the tumor. The resultant radicals induced substantial DNA damage and apoptotic cell death within target tumors under different levels of oxygen availability. As such, this hypoxic TME-responsive synergistic sono-chemodynamic approach offers an ideal means of achieving oxygen-independent free radical generation and enhanced treatment efficacy.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c11017.Methodology of cell culture, orthotopic pancreatic cancer mouse model establishment, assessment of cavitation-induced penetration, and assessment of biocompatibility; Figure S1: TEM image of with US treatment in deoxygenated ddH2O; Figure S2: XPS high-resolution Cu 2p spectrum of Cu-MOF; Figure S3: relative release of Cu from Cu-MOF under different treatments; Figure S4: intracellular GSH depletion measurement; Figure S5: in vivo US imaging of irradiated ; Figure S6: typical confocal micrograph of FITC-dextran (FD) penetration in a mouse tumor; Figure S7: effect of US irradiation alone on Panc02 cells; Figure S8: effect of +US treatment on Panc02 and hTERT-HPNE cells; Figure S9: fluorescence microscopy images of Panc02 cells costained by calcein AM/PI; Figure S10: DSB detection of Panc02 cells under different treatments; Figure S11: body weight changes of mice after treatment with PBS or for 21 days; Figure S12: H&E staining of the organs after treatment with different methods for 15 days (PDF)This article has not yet been cited by other publications.

Intrinsic nucleus-targeted ultra-small metal–organic framework for the type I sonodynamic treatment of orthotopic pancreatic carcinoma

Collagenase-Loaded H-TiO<sub>2</sub> Nanoparticles Enhance Ultrasound Imaging-Guided Sonodynamic Therapy in a Pancreatic Carcinoma Xenograft Model via Digesting Stromal Barriers

Tablet-like TiO2/C nanocomposites for repeated type I sonodynamic therapy of pancreatic cancer

Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal–Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator

Ultrasound-Triggered O2 Bombs: Perfluorobromooctane-Loaded Defect-Rich Metal-Organic Framework for Enhanced Sono-Immunotherapy

Metal–Organic Framework (MOF)‐Based Ultrasound‐Responsive Dual‐Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy

Tumor Metabolism‐Engineered Composite Nanoplatforms Potentiate Sonodynamic Therapy Via Reshaping Tumor Microenvironment and Facilitating Electron–Hole Pairs’ Separation

Dual-modality magnetic resonance/optical imaging-guided sonodynamic therapy of pancreatic cancer with metal—organic nanosonosensitizer

Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.

Metal–organic frameworks as candidates for tumor sonodynamic therapy: Designable structures for targeted multifunctional transformation

Ultrafine Titanium Monoxide (Tio1+X) Nanorods For Enhanced Sonodynamic Therapy

A tumor microenvironment responsive titanium-based nanosonosensitizer for combination sonodynamic-immunotherapy with calcium ion overload

Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy

Nano-Sonosensitized Sonodynamic Nanomedicine Augments Tumor-Selective Catalytic Tumor Eradication

Ultrasmall Iron-Doped Titanium Oxide Nanodots for Enhanced Sonodynamic and Chemodynamic Cancer Therapy

A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies

Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy

Piezoelectric-mediated two-dimensional copper-based metal-organic framework for synergistic sonodynamic and cuproptosis-driven tumor therapy

Liquid exfoliation of TiN nanodots as novel sonosensitizers for photothermal-enhanced sonodynamic therapy against cancer

In-situ TiO2-x decoration of titanium carbide MXene for photo/sono-responsive antitumor theranostics

Ultrasound‐Activated Oxygen and ROS Generation Nanosystem Systematically Modulates Tumor Microenvironment and Sensitizes Sonodynamic Therapy for Hypoxic Solid Tumors